Business, energy, technology, markets and global industry news from Business News Today

New York State Department of Health

PharmaDeviceNews New York State Department of Health
Castle Biosciences’ AdvanceAD-Tx molecular test uses gene expression profiling to support systemic therapy selection for moderate-to-severe atopic dermatitis following New York State approval. Representative image.
Medical Devices & Diagnostics

Castle Biosciences wins crucial New York access, but can AdvanceAD-Tx overcome the reimbursement test?

Castle Biosciences gains New York approval for AdvanceAD-Tx, expanding access while reimbursement and clinical adoption remain decisive.

Read More
Representative image of a laboratory specialist analysing circulating tumour DNA results as Quest Diagnostics expands nationwide access to Haystack MRD cancer monitoring.
Medical Devices & Diagnostics

Why New York approval could accelerate Quest Diagnostics’ Haystack MRD cancer strategy

Quest Diagnostics has taken Haystack MRD nationwide after New York approval. See how ctDNA testing could reshape cancer recurrence monitoring.

Read More
Representative image: AI-powered blood-based lung cancer screening is gaining momentum as DELFI Diagnostics secures New York approval for FirstLook Lung, expanding nationwide access to its laboratory-developed cancer detection test.
Medical Devices & Diagnostics

Why DELFI Diagnostics’ New York approval could shake up the lung cancer screening market

DELFI Diagnostics can now offer FirstLook Lung in all 50 states. Find out what this means for blood-based cancer screening.

Read More
Representative image: A precision oncology laboratory processes blood samples for molecular profiling, reflecting Caris Life Sciences’ Caris Assure submission to New York regulators for blood-based cancer testing authorization.
Medical Devices & Diagnostics

Can Caris Life Sciences turn Caris Assure into a broader precision oncology platform?

Caris wants New York access for Caris Assure. The bigger test is whether liquid biopsy scale can satisfy tougher state oversight.

Read More